Dr. Adam Cohen, MD
Claim this profileInova Schar Cancer Institute
Area of expertise
Glioblastoma
Adam Cohen, MD has run 6 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Adam Cohen, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Inova Schar Cancer Institute
Inova Fairfax Hospital
Clinical Trials Adam Cohen, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
More about Adam Cohen, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Adam Cohen, MD has experience with
- Nivolumab
- Ipilimumab
- Lomustine
- Ribociclib
- Belinostat
- ONC201
Breakdown of trials Adam Cohen, MD has run
Glioblastoma
Brain Tumor
Breast Cancer
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Cohen, MD specialize in?
Adam Cohen, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Adam Cohen, MD currently recruiting for clinical trials?
Yes, Adam Cohen, MD is currently recruiting for 5 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Adam Cohen, MD has studied deeply?
Yes, Adam Cohen, MD has studied treatments such as Nivolumab, Ipilimumab, Lomustine.
What is the best way to schedule an appointment with Adam Cohen, MD?
Apply for one of the trials that Adam Cohen, MD is conducting.
What is the office address of Adam Cohen, MD?
The office of Adam Cohen, MD is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.